Tower Research Capital LLC (TRC) - POINT BIOPHARMA GLOBAL INC ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of POINT BIOPHARMA GLOBAL INC
ValueSharesWeighting
Q3 2023$17,502
-72.2%
2,624
-62.2%
0.00%
-50.0%
Q2 2023$62,904
+285827.3%
6,943
+125.3%
0.00%
+100.0%
Q1 2023$22
+69.2%
3,081
+77.0%
0.00%0.0%
Q4 2022$13
-100.0%
1,741
-84.0%
0.00%0.0%
Q3 2022$84,000
+6.3%
10,883
-5.7%
0.00%
-50.0%
Q2 2022$79,000
+71.7%
11,543
+41.4%
0.00%
+100.0%
Q4 2021$46,000
+53.3%
8,164
+111.4%
0.00%0.0%
Q3 2021$30,0003,8610.00%
Other shareholders
POINT BIOPHARMA GLOBAL INC shareholders Q4 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,909,960$19,409,4333.54%
JOHNSON & JOHNSON 1,000,000$6,670,0002.46%
BVF INC/IL 10,563,748$70,460,1991.90%
SPHERA FUNDS MANAGEMENT LTD. 952,642$6,354,1221.16%
Boxer Capital, LLC 2,500,000$16,675,0000.89%
Pier Capital, LLC 732,936$4,888,6830.79%
Deep Track Capital, LP 2,781,565$18,553,0390.72%
PFM Health Sciences, LP 1,613,516$10,762,1520.51%
Eagle Health Investments LP 306,142$2,041,9670.45%
Onex Canada Asset Management Inc. 772,905$5,155,2760.40%
View complete list of POINT BIOPHARMA GLOBAL INC shareholders